000 | 01647 a2200529 4500 | ||
---|---|---|---|
005 | 20250517072008.0 | ||
264 | 0 | _c20170208 | |
008 | 201702s 0 0 eng d | ||
022 | _a1591-9528 | ||
024 | 7 |
_a10.1007/s10238-015-0401-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhao, Yun-Peng | |
245 | 0 | 0 |
_aValidation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer. _h[electronic resource] |
260 |
_bClinical and experimental medicine _cFeb 2017 |
||
300 |
_a9-18 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
650 | 0 | 4 | _aCarbohydrate Sequence |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycomics _xmethods |
650 | 0 | 4 | _aGlycosylation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _xblood |
650 | 0 | 4 |
_aPancreatic Neoplasms _xblood |
650 | 0 | 4 |
_aPancreatitis _xblood |
650 | 0 | 4 |
_aPolysaccharides _xblood |
650 | 0 | 4 | _aROC Curve |
700 | 1 | _aZhou, Ping-Ting | |
700 | 1 | _aJi, Wei-Ping | |
700 | 1 | _aWang, Hao | |
700 | 1 | _aFang, Meng | |
700 | 1 | _aWang, Meng-Meng | |
700 | 1 | _aYin, Yue-Peng | |
700 | 1 | _aJin, Gang | |
700 | 1 | _aGao, Chun-Fang | |
773 | 0 |
_tClinical and experimental medicine _gvol. 17 _gno. 1 _gp. 9-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10238-015-0401-2 _zAvailable from publisher's website |
999 |
_c25584801 _d25584801 |